Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00803777 · ClinicalTrials.gov registry record · NA

In-Clinic and Home-Use Study of a New Blood Glucose Monitoring System

A NA study, sponsored by Ascensia Diabetes Care.

Completed
Registry status
NA
Development phase
147
Enrollment target

NCT00803777 is a NA study that has completed, run by Ascensia Diabetes Care. The registered enrollment target is 147 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00803777, a NA study, has completed, sponsored by Ascensia Diabetes Care.

COMPLETED
Registry status
NA
Development phase
147 participants
Enrollment target

Study Summary

The purpose of this study is to evaluate the performance and acceptability of a new blood glucose meter.

Interventions

  • DEVICE Investigational Blood Glucose Monitoring System

Trial Details

FieldValue
Enrollment Target 147 participants
Start Date 2008-12
Est. Completion 2009-03
Phase NA

Sponsor

Ascensia Diabetes Care

42 total trials

What the Registry Record Tells You About NCT00803777

The ClinicalTrials.gov registry entry for NCT00803777 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 147 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ascensia Diabetes Care, which has 42 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Investigational Blood Glucose Monitoring System is the first listed.

NCT00803777 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00803777 about?

NCT00803777 is a clinical study titled "In-Clinic and Home-Use Study of a New Blood Glucose Monitoring System". The purpose of this study is to evaluate the performance and acceptability of a new blood glucose meter.

What is the current status of trial NCT00803777?

This trial is currently completed. It is a NA study. The enrollment target is 147 participants. The study started on 2008-12. Estimated completion is 2009-03.

What interventions are being tested in trial NCT00803777?

The interventions under investigation include: Investigational Blood Glucose Monitoring System (DEVICE).

Who is sponsoring clinical trial NCT00803777?

This trial is sponsored by Ascensia Diabetes Care, which has 42 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.